ITREN expanded its International cooperation with Monos Group, Mongolia in April, 2018.
Institute recently visited to Monos Group in Mongolia. The Group involved Drug development Institute, Pharmaceutical University and GMP standard Factory for manufacturing drugs.
The joint researchers will focus on Osteoporosis drug development and Allergy targeted drug delivery.
ITREN expanded its International cooperation with Peking University Shenzhen Graduate School in Dec, 2017.
ITREN has recently started collaborative works with Pf. hou Qiang and Li Shu-peng about utilization of therapeutic nanoparticles for treating neuronal diseases. Impactful research will be expected from these collaborative works.
ITREN expanded its International cooperation with School of Medicine, Yanbian University in July, 2015.
Institute has recently signed Memorandum of Understanding Agreement with School of Medicine, Yanbian University for joint research in tissue engineering and translational work.
Yanbian University has been selected as one of the Top Universities in China and supported by the State “211Project”.
The joint researches will focus on repairing mandibular defect by use of particles and stimulating cartilage regeneration through cartilage cells and synthetic polymer scaffold.
Two influential Reviews published recently: i) Biomaterials control of pluripotent stem cell fate for regenerative therapy, Prog Mater Sci. 2017, and ii) CRISPR/Cas9-based genome editing for disease modeling and therapy: opportunities for non-viral delivery. Chem Rev. 2017
Promoting angiogenesis with mesoporous microcarriers through a synergistic action of delivered silicon ion and VEGF